New diabetes clinical trial: Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients with a ST-segment Elevation Myocardial Infarction
Published on: September 29, 2024 at 11:00PM
Conditions: ST-segment Elevation Myocardial Infarction (STEMI); Diabetes Mellitus; Heart Failure; Myocardial Fibrosis
Interventions: Drug: Dapagliflozin; Drug: Placebo
Sponsors: Hospital Clinic of Barcelona
Active, not recruiting
https://ift.tt/dK3IRGH
Conditions: ST-segment Elevation Myocardial Infarction (STEMI); Diabetes Mellitus; Heart Failure; Myocardial Fibrosis
Interventions: Drug: Dapagliflozin; Drug: Placebo
Sponsors: Hospital Clinic of Barcelona
Active, not recruiting
https://ift.tt/dK3IRGH
Comments
Post a Comment